Literature DB >> 24575440

Why the Cochrane risk of bias tool should not include funding source as a standard item.

Jonathan Ac Sterne1.   

Abstract

Mesh：

Year:  2013        PMID： 24575440     DOI： 10.1002/14651858.ED000076

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


× No keyword cloud information.
  24 in total

1.  Industry Support of Medical Research: Important Opportunity or Treacherous Pitfall?

Authors:  William M Tierney; Eric M Meslin; Kurt Kroenke
Journal:  J Gen Intern Med       Date:  2015-08-26       Impact factor: 5.128

2.  Conflicts of interest in nutritional sciences: The forgotten bias in meta-analysis.

Authors:  Michel Lucas
Journal:  World J Methodol       Date:  2015-12-26

3.  Response to: The evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder is in fact flawed.

Authors:  Pieter J Hoekstra; Jan K Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-09       Impact factor: 4.785

4.  The effect of indapamide vs. bendroflumethiazide for primary hypertension: a systematic review.

Authors:  Tatiana V Macfarlane; Filippo Pigazzani; Robert W V Flynn; Thomas M MacDonald
Journal:  Br J Clin Pharmacol       Date:  2018-11-28       Impact factor: 4.335

5.  How credible are the study results? Evaluating and applying internal validity tools to literature-based assessments of environmental health hazards.

Authors:  Andrew A Rooney; Glinda S Cooper; Gloria D Jahnke; Juleen Lam; Rebecca L Morgan; Abee L Boyles; Jennifer M Ratcliffe; Andrew D Kraft; Holger J Schünemann; Pamela Schwingl; Teneille D Walker; Kristina A Thayer; Ruth M Lunn
Journal:  Environ Int       Date:  2016-02-06       Impact factor: 9.621

6.  Antibiotic therapy for pelvic inflammatory disease.

Authors:  Ricardo F Savaris; Daniele G Fuhrich; Jackson Maissiat; Rui V Duarte; Jonathan Ross
Journal:  Cochrane Database Syst Rev       Date:  2020-08-20

7.  Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank.

Authors:  Andrea V Margulis; Manel Pladevall; Nuria Riera-Guardia; Cristina Varas-Lorenzo; Lorna Hazell; Nancy D Berkman; Meera Viswanathan; Susana Perez-Gutthann
Journal:  Clin Epidemiol       Date:  2014-10-10       Impact factor: 4.790

8.  Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol.

Authors:  Anna Dossing; Simon Tarp; Daniel E Furst; Christian Gluud; Joseph Beyene; Bjarke B Hansen; Henning Bliddal; Robin Christensen
Journal:  BMJ Open       Date:  2014-09-26       Impact factor: 2.692

Review 9.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25

Review 10.  The Navigation Guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth.

Authors:  Juleen Lam; Erica Koustas; Patrice Sutton; Paula I Johnson; Dylan S Atchley; Saunak Sen; Karen A Robinson; Daniel A Axelrad; Tracey J Woodruff
Journal:  Environ Health Perspect       Date:  2014-06-25       Impact factor: 9.031
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.